Philip Home

14.2k citations

221 papers · 10.6k indexed · 3 hit papers · h-index 50

Impact in

Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes, Cardiovascular Risks, and Lipoproteins
Surgery top 0.5%
- Pancreatic function and diabetes

Papers in

Endocrinology, Diabetes and Metabolism 174
- Diabetes Management and Research 131
- Diabetes Treatment and Management 115
- Diabetes, Cardiovascular Risks, and Lipoproteins 36
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 21
Family Practice 3

Co-authors: Nigel C. Jones John J.V. McMurray Ramón Gomis Stuart Pocock M Hanefeld Henning Beck‐Nielsen Matthew C. Riddle Latika Sibal
Journals: Diabetes Care (34 papers)Diabetic Medicine (33 papers)Diabetes Research and Clinical Practice (22 papers)Diabetes Obesity and Metabolism (15 papers)Diabetologia (13 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Philip Home

213 papers receiving 10.0k citations

Hit Papers

align trajectories log scale

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial 2009 · 1.0k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2009 The Lancet
2007 New England Journal of Medicine
2006 Diabetes Care

Peers

Countries citing papers authored by Philip Home

Since Specialization

Citations

This map shows the geographic impact of Philip Home's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Home with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Home more than expected).

Fields of papers citing papers by Philip Home

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Home. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Home. The network helps show where Philip Home may publish in the future.

Co-authors

The 25 scholars most cited alongside Philip Home, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip Home Line = papers co-authored together Philip Home links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics Diabetes Obesity and Metabolism ·Philip Home, Rory J. McCrimmon, Julio Rosenstock, Matthias Blüher, K. Syragakid, 後藤慎吉, Landobasa Y M Tobing, Francesco Giorgino, (unknown)	2022	5
2	New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4) Diabetes Care ·Philip Home, Richard M. Bergenstal, Geremia B. Bolli, M. Ziemen, Maria Rojeski, Tomoki Ikai, Matthew C. Riddle	2015	142
3	An Overview of Current Regulatory Requirements for Approval of Biosimilar Insulins Diabetes Technology & Therapeutics ·Lutz Heinemann, Hootan Khatami, Ross A. McKinnon, Philip Home	2015	29
4	Cancer and bone fractures in observational follow-up of the RECORD study Acta Diabetologica ·Nigel C. Jones, Paula Curtis, Philip Home	2014	10
5	Safety, Tolerability, and Efficacy of Insulin Aspart in People with Type 2 Diabetes, as Biphasic Insulin Aspart or with Basal Insulin: Findings from the Multinational, Non-Interventional A1chieve Study Diabetes Therapy ·Sudip Halder, Siddharth Shah, Yuxiu Li, 隆男細矢, Grazielle de Oliveira, Philip Home	2014	2
6	Comparison of National/Regional Diabetes Guidelines for the Management of Blood Glucose Control in non-Western Countries Diabetes Therapy ·Philip Home, Horace W. Harrell, Anja Rangen, Pradana Soewondo, Grazielle de Oliveira, León Litwak, Serdar Güler, Sandy Alferro Dion, А. В. Зилов	2013	25
7	Biphasic Insulin Aspart 30 in Insulin-Naive People with Type 2 Diabetes in Non-western Nations: Results from a Regional Comparative Multinational Observational Study (A ₁ chieve) Diabetes Technology & Therapeutics ·Siddharth Shah, Wenying Yang, Г.Р. Наумова, Rachid Malek, Ole Molskov Bech, Philip Home	2013	3
8	Friedewald equation underestimates low‐density lipoprotein cholesterol at low concentrations in young people with and without Type 1 diabetes Diabetic Medicine ·Latika Sibal, R. Dermot G. Neely, A.F. Jones, Philip Home	2009	35
9	A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes Diabetologia ·Julio Rosenstock, Melanie J. Davies, Philip Home, J. Larsen, Christoph Koenen, Guntram Schernthaner	2008	342
10	The diabetes epidemic and the developing world Practical Diabetes International ·Philip Home	2006	1
11	Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes Diabetes Research and Clinical Practice ·Philip Home, Per Hallgren, K. H. Usadel, T Sane, Jens Faber, Valdemar Grill, Hans Friberg	2005	29
12	Interval between insulin injection and meal in relation to glycated haemoglobin Practical Diabetes International ·Mohamad Rozkit Bouti, Jennifer A. Hyder, Philip Home	2001	9
13	Insulin resistance is not central to the burden of diabetes Diabetes/Metabolism Reviews ·Philip Home	1997	6
14	Report on renal disease in diabetes. PubMed ·Gian Carlo Viberti, S. M. Marshall, Robin N. Beech, Virginia Brown, 王农, Nigel Higson, Philip Home, H. Keen, Michael Plant, John Walls	1996	16
15	An Approach to Manageable Datasets in Diabetes Care Diabetic Medicine ·William Alexander, Colin Bradshaw, Roger Gadsby, Philip Home, P Kopelman, Hanna Barreto Dias, 繁太佐々木, sup 李翠翠	1994	9
16	Repeatability of measurements and sources of variability in tests of cardiovascular autonomic function Heart ·Amanda Marques, Philip Home, Alan Murray	1992	32
17	Morphology of Palpably Abnormal Injection Sites and Effects on Absorption of Isophane(NPH) Insulin Diabetic Medicine ·Jonathan Thow, A.B. Johnson, E. A. Carreras, Roy Taylor, Philip Home	1990	43
18	Different Absorption of Isophane (NPH) Insulin from Subcutaneous and Intramuscular Sites Suggests a Need to Reassess Recommended Insulin Injection Technique Diabetic Medicine ·Jonathan Thow, A.B. Johnson, Gregory Fulcher, Philip Home	1990	38
19	Intermediate acting insulin given at bedtime: effect on blood glucose concentrations before and after breakfast. BMJ ·Alice J. Francis, Philip Home, I. Hanning, K. G. M. M. Alberti, W. M. G. Tunbridge	1983	51
20	Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trial. BMJ ·Richard Worth, Philip Home, Desmond G. Johnston, J. Anderson, L. Ashworth, Jacky M. Burrin, D. J. Appleton, C Binder, K. G. M. M. Alberti	1982	108

About Philip Home

Philip Home is a scholar working on Endocrinology, Diabetes and Metabolism, Family Practice, Surgery, Genetics and Statistics and Probability, having authored 221 papers that have together received 10.6k indexed citations. Recurring topics across this work include Diabetes Management and Research (131 papers), Diabetes Treatment and Management (115 papers), Pancreatic function and diabetes (50 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (36 papers), Metabolism, Diabetes, and Cancer (34 papers), Diabetes and associated disorders (28 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (21 papers) and Diet and metabolism studies (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (7.8k citations), Surgery (3.3k citations), Transplantation (169 citations), Genetics (1.7k citations) and Cardiology and Cardiovascular Medicine (989 citations). Philip Home has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Nigel C. Jones, John J.V. McMurray, Ramón Gomis, Stuart Pocock, M Hanefeld, Henning Beck‐Nielsen, Matthew C. Riddle, Latika Sibal, Anna Lindholm Olinder and Michel Komajda. Their work appears in journals such as Diabetes Care, Diabetic Medicine, Diabetes Research and Clinical Practice, Diabetes Obesity and Metabolism and Diabetologia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact